Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.
Novo Nordisk Says It's Suing Hims to Halt Obesity Drug Copycats bloomberg.comNovo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock plunges 27% CNBCHims & Hers Withdraws Knockoff Weight-Loss Pill After Regulatory Scrutiny The New York TimesWegovy maker sues Hims & Hers after company launches $49 weight-loss pill USA Today
Dow retreats after passing 50,000 mark as traders brace for jobs, inflation data this week: Live updates CNBCStock market today: US stocks tip higher after Dow tops 50,000 milestone as jobs, inflation reports loom Yahoo FinanceStock Market Today: Dow set to hold 50,000 mark, as S&P 500, Nasdaq poised for lower start; Nikkei surges after Japan election MarketWatchWhy Are Stock Market Futures Up Today, 2/9/26? TipRanks
Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk's Wegovy oral weight-loss drug.
